Literature DB >> 7105621

Hydralazine and furosemide kinetics.

A Nomura, H Yasuda, K Katoh, T Akimoto, K Miyazaki, T Arita.   

Abstract

Fursosemide kinetics were studied in 25 patients with congestive heart failure. The elimination half-life (t1/2) was longer and the elimination rate constant and the plasma clearance smaller in patients with advanced (n = 15) than in those with moderate (n = 10) failure. Furosemide kinetics with and without hydralazine were compared in eight patients with advanced heart failure. Furosemide t1/2 patients receiving both drugs fell from 96 +/- 16 to 81 +/- 15 min (P less than 0.02), elimination rate constant increased from 0.0186 +/- 0.0056 to 0.0214 +/- 0.0068 min -1 (P less than 0.05), and plasma clearance rose from 72.6 +/- 18.5 to 88.1 +/- 26.9 ml/min (P less than 0.01). Renal clearance rose from 45.4 +/- 12.0 to 60.9 +/- 19.0 ml/min (P less than 0.01) and creatinine clearance was unchanged. We conclude that hydralazine affects furosemide kinetics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105621     DOI: 10.1038/clpt.1982.164

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Serum alpha-1-acid glycoprotein and protein binding of disopyramide in patients with congestive heart failure.

Authors:  A Nomura; H Yasuda; T Kobayashi; S Kishino; N Kohri; K Iseki; K Miyazaki
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.